Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vectibix in Cutaneous Squamous Cell Carcinoma
NCT01129154Phase 2Unknown
- Start
- Aug 2010
- Primary completion
- Jul 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab in squamous cell carcinoma of the skin (cSCC). Primary endpoint: Overall Response Rate. Status: unknown.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the skin (cSCC)
Beyond the preview
Go deeper on NCT01129154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129154.